Clinical Trial Update: Stony Brook Medicine Anti-Inflammatory Trial [Phase 4]

View source ↗

Summary

Stony Brook University announced an anti-inflammatory trial for Major Depressive Disorder in Phase 4. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Stony Brook University | Conditions: Major Depressive Disorder | Phase 4 | Status: NOT_YET_RECRUITING